Clinician contextualizes rarity of cases relative to GLP-1 user population
2 Sep 13 1:00 PM · 10d ago · 5 articles · 2 sources · development 2 of 2
Dr. Karthik Achari, a Chicago-based clinician not involved in the study, told Fox News that the 15 cases identified must be viewed in perspective against millions of people taking GLP-1 medications. He explained the mechanism: the drugs reduce appetite but not the body's nutritional requirements, and certain patients—those with persistent nausea, rapid weight loss on minimal food intake, prior bariatric surgery, or heavy alcohol use—face higher risk.
“Researchers went through adverse event reports and the medical literature and found a small number of cases, 15, of Wernicke encephalopathy in people taking GLP-1 drugs. That's out of millions of people on these medications. So this is rare.”
Dr. Karthik AchariIsraeli research team Study authorsDr. Karthik Achari Chicago-based clinician, PepMD founder
The whole story articles the bright band is this development · numbered dots are the others · click one to jump
What was reported 1 claim about this development
-
first by NTD News, 8d ago
What people said 1 voice · verbatim
-
S
Rare brain condition identified in some Ozempic, Wegovy users: Study https:// thehill.com/policy/healthcare/ 6086303-glp-1-vitamin-deficiency-rare-brain-disorder-study/ # BigPharma # brain # Ozempic # Wegovy
All 2 developments of Israeli study links GLP-1 drugs to rare brain disorder from… →
NewswiresGoogle NewsMastodon